Catalyst Biosciences, Inc. (CBIO) Company Profile
Catalyst Biosciences, Inc., formerly Targacept, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on creating and developing medicines to address serious medical conditions. The Company focuses its product development efforts in the fields of hemostasis, including the treatment of hemophilia and surgical bleeding, and inflammation, including prevention of delayed graft function (DGF) in renal transplants and the treatment of dry age-related macular degeneration (dry AMD), a condition that can cause visual impairment or blindness. The Company’s advanced program is a coagulation Factor VIIa variant, CB 813d, that has completed a Phase I clinical trial in severe hemophilia A and B patients. In addition to its lead Factor VIIa program, it has approximately two other coagulation factors, a Factor IX variant, CB 2679d/ISU 304, that is in advanced preclinical development, and a Factor Xa variant that has reached the advanced lead preclinical-stage of development.
News about CBIO
Catalyst Biosciences: The Next Acquisition Target?
Catalyst Biosciences (CBIO) has been having a good time as its Hemophilia B program has continued to advance. Just this past week, it had announced positive phase 1/2 data for its Hemophilia B drug CB 2679d. This data highlights the importance for a ...Read More>>>
25 Stocks Moving In Friday's Mid-Day Session
Related 31 Stocks Moving In Thursday's Mid-Day Session 22 Stocks Moving In Thursday's Pre-Market Session Related SIGM 23 Stocks Moving In Friday's Pre-Market Session ...Read More>>>
Cannell Capital Llc Buys LendingClub Corp, Veracyte Inc, eHealth Inc, Sells IntraLinks Holdings Inc,
Jackson, WY, based Investment company Cannell Capital Llc buys LendingClub Corp, Veracyte Inc, eHealth Inc, Perma-Pipe International Holdings Inc, Heritage-Crystal Clean Inc, QuinStreet Inc, Alliance HealthCare Services Inc, Liberty Tax Inc, Craft Br...Read More>>>
Week In Review: Zai Lab Partners With GE On China Biologics Manufacturing
Deals and Financings Zai Lab of Shanghai will expand into biologic drug manufacturing through a partnership with GE Healthcare, a company that makes biomanufacturing equipment. The two companies will cooperate on a facility in Suzhou's BioBay Park, a...Read More>>>
Mid-Afternoon Market Update: Fuwei Films Drops After Q4 Results; Diana Shipping Shares Surge
Toward the end of trading Friday, the Dow traded up 0.11 percent to 20,686.09 while the NASDAQ rose 0.09 percent to 5,884.28. The S&P also rose, gaining 0.09 percent to 2,359.51. Leading and Lagging Sectors Friday afternoon, the non-cyclical con...Read More>>>